MedTech Weekly Wrap - 22 Dec 24

Weekly Med Tech News post by Abnormal Docs

🩺 Medical Devices

• FDA greenlights expansion of BiVacor artificial heart study

  

  BiVacor total artificial heart (TAH)

• Merit Medical Systems announced today that it received FDA premarket approval for its Wrapsody cell-impermeable endoprosthesis.

  

  The Wrapsody cell-impermeable endoprosthesis

• DuraStat partners with Medtronic on surgical tissue closure tech

  

  Image from Durastat website

🎓 Scholarships/Internships

• Deadline: 9 Jan 25 NIG Internship 2025 Japan is receiving applications for biotech research

  

• Deadline: 15 Jan 25 The International Journal of Medical Students (IJMS) invites applications for its 2025 Editorial Team!

---

🆕 New Approval

• Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

• FDA approves drug “olezarsen” to reduce triglycerides in adult patients with familial chylomicronemia syndrome (FCS)

• FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus host disease in pediatric patients

• FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer

• US FDA approves Novo Nordisk's bleeding disorder drug

  ---

🤖 AI & ML

Health Systems Are Struggling to Keep Up With AI—A National Registration System Could Help

---

🌎 World

Dinga Dinga Virus: 10 Things to Know About Mysterious Virus Outbreak In Uganda

🇮🇳 India

• MoS Health Anupriya Patel highlights growth potential of India's medical device sector

• Rohan Mirchandani, Co-Founder of Epigamia, Dies of Cardiac Arrest At 42

  

🔍 Research

Controversial COVID study that promoted unproven treatment retracted after four-year saga

🎯 Opportunities

Want to join our team? 👉🏻 Click here

Follow us on

1. Twitter

2. Instagram

3. LinkedIn

4. WhatsApp channel